Healthcare - Biotechnology - NASDAQ - GB
$ 21.79
-3.5 %
$ 1.5 B
Market Cap
-6.64
P/E
INCOME STATEMENT
27 M
REVENUE
-190 M
OPERATING INCOME
-181 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Bicycle Therapeutics plc
| Revenue | 27 M |
| Cost Of Revenue | 156 M |
| Gross Profit | -130 M |
| Operating Expenses | 217 M |
| Operating Income | -190 M |
| Other Expenses | -9.28 M |
| Net Income | -181 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | |
|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||
| Revenue | 27.0 | 14.5 | 11.7 | 10.4 | 13.8 | 7.1 | 2.1 | 0 |
| GROSS PROFIT | ||||||||
| Cost Of Revenue | 156.5 | 3.7 | 44.9 | 33.1 | 25.5 | 20.8 | 11.9 | 0.3 |
| Gross Profit | (129.5) | 10.8 | (33.2) | (22.8) | (11.7) | (13.6) | (9.8) | (0.3) |
| OPERATING INCOME | ||||||||
| Operating Expenses | 216.9 | 131.1 | 77.3 | 62.4 | 40.1 | 28.9 | 18.3 | 13.2 |
| Selling, General and Administrative Expenses | 59.8 | 49.5 | 32.4 | 29.2 | 14.6 | 8.1 | 6.4 | 3.5 |
| Research and Development Expenses | 156.5 | 81.6 | 44.9 | 33.1 | 25.5 | 20.8 | 11.9 | 9.8 |
| Operating Income | (189.9) | (116.7) | (65.6) | (52.0) | (26.3) | (21.7) | (16.2) | (13.5) |
| PRE-TAX INCOME | ||||||||
| Interest Income Expense | 3.3 | 3.3 | 3.0 | 0.5 | 0 | 0 | 0 | 0 |
| Total Other Income | 10.7 | 2.4 | (2.9) | 0.2 | (4.6) | (0.5) | 69 K | 37.9 K |
| Pre-Tax Income | (179.2) | (114.2) | (68.5) | (51.7) | (30.9) | (22.2) | (16.3) | (13.5) |
| NET INCOME | ||||||||
| Tax Provision | 1.5 | (1.5) | (1.7) | (0.7) | (0.3) | (0.4) | 23 K | 20.9 K |
| Net Income | (180.7) | (112.7) | (66.8) | (51.0) | (30.6) | (21.8) | (16.3) | (13.5) |
| EPS | 5.08 | 3.8 | 2.67 | 2.66 | 2.77 | 1.64 | 1.22 | 0.76 |